While health policy has historically been divided along party lines, there is growing agreement among national experts and researchers about the underlying problems driving healthcare costs and the solutions that can help address them.
In fact, some of the strongest calls for healthcare reform are coming from people with very different political backgrounds, as well as non-partisan experts and research institutes.
Here is what they are saying.
Ezekiel Emanuel, MD, PhD — Former senior health policy advisor to President Barack Obama.
Brian Blase, PhD — Former senior economic policy advisor to President Donald Trump and president of the Paragon Health Institute.
In a Washington Post op-ed, Emanuel and Blase jointly write: “Americans now spend over $1.6 trillion annually on hospital costs — nearly a third of total health care spending. Since 2000, hospital prices have more than tripled, rising nearly twice as fast as general health care prices and three times as fast as inflation. Reforming payment policy and encouraging competition would help bring down high hospital prices. Medicare and private insurers pay much more for services performed in a hospital outpatient department than in a doctor’s office, ambulatory surgery center or imaging center. These payment differences incentivize hospitals to acquire physician practices and bill insurers and patients at the higher rate, which raises costs without improving care... This could save taxpayers and beneficiaries nearly $200 billion over a decade and reduce hospital consolidation, which would lower private insurance premiums.”
Alex Azar — Secretary of Health and Human Services under President Donald Trump.
Kathleen Sebelius — Secretary of Health and Human Services under President Barack Obama.
In a STAT op-ed, the two former HHS secretaries made a joint case for site-neutral payment reform, arguing that patients and taxpayers should not pay more for the same service simply because it is delivered in a hospital-owned setting: "People should pay for the care they receive, not for the sign on the door." The two argued that higher payments based solely on the location of care encourage hospital consolidation, make it harder for independent physician practices to compete and ultimately increase costs for patients and payers.
Anthony DiGiorgio, DO, MHA — University of California, San Francisco's Philip R. Lee Institute for Health Policy Studies.
Wayne Winegarden, PhD — Senior fellow in business and economics at the Pacific Research Institute.
In a JAMA Health Forum article, DiGiorgio and Winegarden examined whether the 340B Drug Pricing Program is delivering on its original mission of helping vulnerable patients: “A 2021 study found no evidence that hospitals entering the 340B program increased their care for underserved populations any more than institutions not participating in the program..Another study showed hospitals exhibit strategic corporate behavior to meet, without exceeding, the minimum share of low-income patients to qualify for the 340B program… The design of the 340B program imposes costs on the broader health care system. The discounts are not passed on to patients.”
Congressional Budget Office (CBO) — The nonpartisan federal agency responsible for analyzing the budgetary and economic effects of legislation.
In an analysis, CBO researchers noted that providers are winning more than 80% of arbitration cases and receiving awards significantly higher than anticipated under the federal No Surprises Act. Those outcomes could give providers additional leverage in contract negotiations, potentially driving up negotiated prices and insurance premiums. The agency cautioned: “outcomes from arbitration suggests that the law could cause premiums to increase if outcomes from arbitration enhance providers' ability to secure higher prices by credibly threatening to stay out of network.”
The message from these experts is consistent: healthcare affordability requires addressing the underlying practices and incentives that drive costs higher.
As North Carolina prepares for a new General Assembly in 2027, lawmakers have an opportunity to put these ideas into practice. Surprise billing, site-neutral payments and 340B reform are three areas where meaningful progress can help lower costs for families, employers and taxpayers.
Healthcare policy may not always be bipartisan. But the need to make healthcare more affordable—and several practical opportunities to do so—clearly transcend party lines.



